www.statnews.com Open in urlscan Pro
2606:4700::6812:1ccd  Public Scan

Form analysis
4 forms found in the DOM

GET https://www.statnews.com/

<form class="header-search search-form" role="search" method="get" action="https://www.statnews.com/">
  <input type="search" class="search-form-field" placeholder="Search …" value="" name="s" aria-label="Search …">
  <button type="submit" class="header-btn header-btn-search">Search</button>
</form>

Name: page — POST /wp-json/stat-hubspot/v1/signup

<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="page">
  <div class="stat-hubspot-signup-fields">
    <div class="stat-form-inline" data-stat-newsletter-no-step-2="">
      <div class="stat-form-full">
        <input type="email" name="email" placeholder="Email Address" aria-label="Enter your email" required="">
        <div class="stat-field-error">Please enter a valid email address.</div>
        <input type="submit" value="Sign Up">
        <input type="hidden" name="stat_newsletters_source" value="homepage_widget">
        <input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
      </div>
      <div class="stat-form-full stat-form-checkbox-wrapper">
        <input type="checkbox" name="marketing_opt_in" id="marketing" value="1">
        <label for="marketing">I'd like to be emailed about new content, events, and products.</label>
      </div>
    </div>
  </div>
  <div class="stat-hubspot-signup-response"></div>
</form>

Name: modal — POST /wp-json/stat-hubspot/v1/signup

<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="modal">
  <div class="stat-hubspot-signup-fields">
    <div class="stat-form-full">
      <div class="stat-form-brand">
        <img loading="lazy" decoding="async" src="https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black.png" alt="Morning Rounds" class="stat-form-brand-logo" width="700" height="323">
        <p class="stat-form-brand-description">Understand how science, health policy, and medicine shape the world every day</p>
      </div>
      <input type="email" name="email" required="" placeholder="Email Address">
      <div class="stat-form-select-wrapper">
        <select name="industry_internal_" class="has-faux-placeholder is-empty" aria-label="Industry">
          <option value="" selected="">Industry</option>
          <option value="Academia">Academia</option>
          <option value="Advertising/Communications Agency">Advertising/Communications Agency</option>
          <option value="Advocacy/Non-Profit">Advocacy/Non-Profit</option>
          <option value="Banking">Banking</option>
          <option value="Biotech">Biotech</option>
          <option value="Clinical Research Organization">Clinical Research Organization</option>
          <option value="Consulting Firm">Consulting Firm</option>
          <option value="Consumer Health">Consumer Health</option>
          <option value="Financial Services (Other)">Financial Services (Other)</option>
          <option value="Government">Government</option>
          <option value="Healthcare Payer/Insurance">Healthcare Payer/Insurance</option>
          <option value="Health Tech">Health Tech</option>
          <option value="Hospital Systems/Provider">Hospital Systems/Provider</option>
          <option value="Law">Law</option>
          <option value="Media">Media</option>
          <option value="Medical Devices">Medical Devices</option>
          <option value="Medical Technology">Medical Technology</option>
          <option value="Pharmaceuticals">Pharmaceuticals</option>
          <option value="Pharmacy/Retail">Pharmacy/Retail</option>
          <option value="Real Estate">Real Estate</option>
          <option value="Trade Association">Trade Association</option>
          <option value="Technology">Technology</option>
          <option value="Venture Capital">Venture Capital</option>
        </select>
      </div>
      <input type="submit" class="stat-button-primary" value="Sign up for our newsletter">
      <span class="privacy-link"><a href="/privacy/" target="_blank" rel="noopener noreferrer">Privacy Policy</a></span>
      <input type="hidden" name="stat_newsletters_source" value="bc_modal">
      <input type="hidden" name="stat_newsletters_campaign" value="">
      <input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
    </div>
  </div>
  <div class="stat-hubspot-signup-response"></div>
</form>

Name: default — POST /wp-json/stat-hubspot/v1/signup

<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="default">
  <div class="stat-hubspot-signup-fields">
    <input type="email" name="email" placeholder="Enter your email" aria-label="Enter your email" required="">
    <button class="stat-arrow-submit" aria-label="Submit">
      <span class="far fa-arrow-right" aria-hidden="true"></span>
    </button>
    <input type="hidden" name="stat_newsletters_source" value="footer_bar">
    <input type="hidden" name="stat_newsletters_campaign" value="">
    <input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
  </div>
  <div class="stat-hubspot-signup-response"></div>
</form>

Text Content

Skip to Main Content
Explore what it takes to make the health care system work.
research
Hospitals
Congress
STAT Madness: Apply now to be the next MVP of health & medicine 
 * Newsletters
 * Log In
 * My Account
 * Subscribe Now

My Account
 * Settings
 * Billing
 * Log In

Reporting from the frontiers of health and medicine
 * Newsletters
 * Log In
 * My Account
 * Subscribe Now

 * Biotech
 * Pharma
 * Public Health
 * Health Tech
 * Policy
 * Science
 * First Opinion
 * STAT+
 * STAT Events
 * 


Search
 * Log In
 * Subscribe Now
 * My Account

Home

News
 * Latest
 * Business
   * Biotech
   * Pharma
   * Health Tech
   * Health Insurance
   * Hospitals
   * Medical Devices
 * Washington
   * Policy
   * FDA
   * CDC
   * NIH
 * Science
   * CRISPR
   * Gene Therapy
   * Research
   * Neuroscience

 * Public Health
   * Addiction
   * Covid-19
   * Abortion
   * Health Disparities
   * Infectious Disease
   * Mental Health
 * Disease
   * Cancer
   * Cardiovascular Disease
   * Chronic Disease
   * Diabetes
   * Dementia
   * Obesity
 * Features
   * The Obesity Revolution
   * Living With
   * Death Sentence

Newsletters
Opinion
Columns
 * Adam Feuerstein
 * Matthew Herper
 * Jennifer Adaeze Okwerekwu
 * Ed Silverman

Podcasts
Video
Tools & Trackers
 * STAT Trials Pulse
 * CRISPR Trackr
 * Breakthrough Device Tracker
 * Generative AI Tracker
 * Obesity Drug Tracker

Events
 * Breakthrough Summit East
 * All Events

Community
 * STAT+ Connect
 * Wunderkinds

Reports
E-Books

Don't miss out

Subscribe to STAT+ today, for the best life sciences journalism in the industry

Learn more


STAT — REPORTING FROM THE FRONTIERS OF HEALTH AND MEDICINE


LATEST

 * 15 min ago
   
   
   BERNIE SANDERS PROPOSES SUBPOENAS OF CEOS OF J&J, MERCK ON DRUG PRICES

 * 2 hr ago
   
   
   PIPELINES FROM HIGH SCHOOL TO HEALTH CARE JOBS TO BE CREATED BY NEW BLOOMBERG
   PHILANTHROPIES INITIATIVE

 * 5 hr ago
   
   
   APPLE WATCH PULSE OXIMETER FEATURE REMOVED TO COMPLY WITH BAN

 * 
 * 5 hr ago
   
   
   THE XBI COMEDOWN AFTER JPM

 * 10 hr ago
   
   
   A NEW HHS RULE TAKES A FAR TOO NARROW APPROACH TO HEALTH CARE DATA
   INTEROPERABILITY

 * 20 hr ago
   
   
   CONGRESS’ NEGOTIATIONS OVER DOC PAY, HEALTH CENTERS FELL APART AHEAD OF
   SPENDING EXTENSION

More Stories


DON'T MISS

Join fellow industry leaders in NYC this March for Breakthrough Summit East

Learn more


TOP STORIES

Health


PUMPING BREASTMILK IN BATHROOMS IS A COMMON, ALBEIT UNSPOKEN, PRACTICE AT HEALTH
CARE CONFERENCES

Nearly 100 people reached out to STAT about the difficulty of pumping breastmilk
at the J.P. Morgan Healthcare Conference.

By Tara Bannow

10 hr ago

 * JPM 2024

By Tara Bannow

Health
Health 31 min ago


COULD LONG COVID’S SIGNS OF IMMUNE DYSREGULATION IN THE BLOOD LEAD TO A
DIAGNOSTIC TEST?

By Elizabeth Cooney

Health
Health 10 hr ago


AMID A DIRE NATIONWIDE THERAPIST SHORTAGE, COULD LAY COUNSELORS HELP CLOSE THE
GAP?

By Grace Rubenstein


Biotech
Biotech 3 hr ago


STAT PLUS: CRISPR-EDITED PIG LIVER FROM EGENESIS PASSES FIRST TEST IN BRAIN-DEAD
HUMAN, RESEARCHERS SAY

By Megan Molteni

Health Tech
Health Tech 10 hr ago


STAT PLUS: HOW DIGITAL THERAPEUTICS COMPANIES ARE IMPROVISING WHEN INSURANCE
COVERAGE ISN’T GUARANTEED

By Mario Aguilar




MOST READ

The Readout


READOUT NEWSLETTER: UPDATES ON VERTEX, KYVERNA, ELI LILLY

1 of 4 most read today

Health


RISKY WEIGHT LOSS PRODUCTS OFTEN USED BY TEENS GLOBALLY, PER STUDY

2 of 4 most read today

First Opinion


MULTISPECIALTY MEDICAL GROUPS ARE RAPIDLY LOSING THEIR INDEPENDENCE

3 of 4 most read today

Health Care Inc.


MEDICARE ADVANTAGE TODAY, EXPLAINED IN ONE CHART

4 of 4 most read today


MOST READ IN STAT+

Politics


STAT PLUS: COPAY COUPONS TO COUNT TOWARD DEDUCTIBLES, AFTER BIDEN COURT MOVE

1 of 5 most read today

Insurance


STAT PLUS: PRIOR AUTHORIZATION WILL HAVE TO MOVE FASTER UNDER NEW BIDEN RULE

2 of 5 most read today

Exclusive


STAT PLUS: CONGRESS' DOC PAY, HEALTH CENTER TALKS JUST FAILED. WHAT'S NEXT?

3 of 5 most read today

Health Tech


STAT PLUS: FDA CLEARS AI TOOL FOR DETECTING SKIN CANCER

4 of 5 most read today

Health


STAT PLUS: STUDY FINDS TESTOSTERONE TREATMENT DIDN'T LOWER FRACTURE RISK IN MEN

5 of 5 most read today


SPONSORED

Advertisement




FIRST OPINION

 * First Opinion
   
   
   A NEW HHS RULE TAKES A FAR TOO NARROW APPROACH TO HEALTH CARE DATA
   INTEROPERABILITY

 * First Opinion
   
   
   THE DECLINE AND FALL OF ELITE MULTISPECIALTY MEDICAL GROUPS

 * 
 * First Opinion
   
   
   CORD BLOOD BANKING SOUNDS LIKE A GREAT IDEA — UNTIL YOU REALIZE WHAT IT COSTS
   BABIES

All First Opinion


STAT+


YOUR GO-TO SOURCE FOR THE WORLD OF LIFE SCIENCES, MEDICINE, AND BIOPHARMA.
SUBSCRIBE NOW.

Cancel anytime.

Subscribe now


TRENDING NOW

All STAT+ Stories


DEWPOINT THERAPEUTICS CUTS 15% OF STAFF, ACKNOWLEDGES MERCK, PFIZER BROKE OFF
PARTNERSHIPS OVER BUZZY SCIENCE


FDA EXPANDS APPROVAL OF CRISPR-BASED MEDICINE TO TREAT BETA THALASSEMIA


MORE PATIENTS ARE GETTING THEIR MEDS ONLINE. BIG PHARMA WANTS IN ON THE ACTION


AT HEALTH CARE’S BIGGEST INVESTOR CONFERENCE, AI’S HIGH HOPES COLLIDED WITH
SKEPTICISM

All STAT+ Stories
All Events

More From STAT

More From STAT

More From STAT


EVENTS

STAT offers a variety of in-person and virtual events throughout the year.

All Events

21

Mar


2024 STAT BREAKTHROUGH SUMMIT EAST

New York, NY March 21, 2024

At 2024 Breakthrough Summit East, we gather industry leaders & patients to find
real answers on how to make sure that science is benefiting the ones who
desperately need it.

All Events



MORE STORIES

 * Latest
 * Most Read
 * Subscriber Only
 * Opinion
 * 

Politics
Politics 15 min ago


BERNIE SANDERS PROPOSES SUBPOENAS OF CEOS OF J&J, MERCK ON DRUG PRICES

By Rachel Cohrs • 15 min ago

Health Care
Health Care 2 hr ago


STAT PLUS: PIPELINES FROM HIGH SCHOOL TO HEALTH CARE JOBS TO BE CREATED BY NEW
BLOOMBERG PHILANTHROPIES INITIATIVE

By Christopher Huffaker — Boston Globe • 2 hr ago

Health Tech
Health Tech 5 hr ago


STAT PLUS: APPLE WATCH PULSE OXIMETER FEATURE REMOVED TO COMPLY WITH BAN

By Lizzy Lawrence • 5 hr ago

The Readout
The Readout 5 hr ago


THE XBI COMEDOWN AFTER JPM

By Damian Garde • 5 hr ago

First Opinion
First Opinion 10 hr ago


A NEW HHS RULE TAKES A FAR TOO NARROW APPROACH TO HEALTH CARE DATA
INTEROPERABILITY

By John C. (Jack) Lewin and Jane Delgado • 10 hr ago

Exclusive
Exclusive 20 hr ago


STAT PLUS: CONGRESS’ NEGOTIATIONS OVER DOC PAY, HEALTH CENTERS FELL APART AHEAD
OF SPENDING EXTENSION

By Rachel Cohrs • 20 hr ago

Health
Health 22 hr ago


STAT PLUS: TESTOSTERONE DIDN’T LOWER FRACTURE RISK IN A SURPRISING NEW STUDY.
RESEARCHERS HAVE THEORIES ABOUT WHY

By Annalisa Merelli • 22 hr ago

Insurance
Insurance 22 hr ago


STAT PLUS: BIDEN CHANGES WILL FORCE HEALTH INSURERS TO SPEED UP AND GET MORE
SPECIFIC IF THEY WANT TO DENY CARE

By Brittany Trang • 22 hr ago


Politics
Politics 24 hr ago


STAT PLUS: COPAY COUPONS FOR SOME DRUGS MUST COUNT TOWARD DEDUCTIBLES, AFTER
BIDEN COURT MOVE

By John Wilkerson • 24 hr ago

Health Tech
Health Tech 1 day ago


STAT PLUS: GENERAL CATALYST TO BUY OHIO-BASED SAFETY NET HEALTH SYSTEM SUMMA
HEALTH

By Mohana Ravindranath • 1 day ago

The Readout
The Readout 1 day ago


THE BIG ANY-DAY-NOW BIOTECH NEWS WE’RE KEEPING AN EYE ON

By Damian Garde • 1 day ago

Health Tech
Health Tech 1 day ago


STAT PLUS: FDA CLEARS AI SKIN CANCER DETECTOR FOR PRIMARY CARE DOCTORS TO USE

By Lizzy Lawrence • 1 day ago

Pharma
Pharma 1 day ago


STAT PLUS: MORE PATIENTS ARE GETTING THEIR MEDS ONLINE. BIG PHARMA WANTS IN ON
THE ACTION

By Katie Palmer • 1 day ago

All Stories
Health Tech
Health Tech 10 hr ago


STAT PLUS: HOW DIGITAL THERAPEUTICS COMPANIES ARE IMPROVISING WHEN INSURANCE
COVERAGE ISN’T GUARANTEED

By Mario Aguilar • 10 hr ago

Health Tech
Health Tech 1 day ago


STAT PLUS: AT HEALTH CARE’S BIGGEST INVESTOR CONFERENCE, AI’S HIGH HOPES
COLLIDED WITH SKEPTICISM

By Casey Ross, Matthew Herper, and Mohana Ravindranath • 1 day ago

Pharma
Pharma 1 day ago


STAT PLUS: MORE PATIENTS ARE GETTING THEIR MEDS ONLINE. BIG PHARMA WANTS IN ON
THE ACTION

By Katie Palmer • 1 day ago

Health
Health 10 hr ago


AMID A DIRE NATIONWIDE THERAPIST SHORTAGE, COULD LAY COUNSELORS HELP CLOSE THE
GAP?

By Grace Rubenstein • 10 hr ago

Politics
Politics 15 min ago


BERNIE SANDERS PROPOSES SUBPOENAS OF CEOS OF J&J, MERCK ON DRUG PRICES

By Rachel Cohrs • 15 min ago

First Opinion
First Opinion 1 week ago


PUMPING MILK AT JPM WAS A NIGHTMARE. IT’S PART OF A BIGGER PROBLEM IN THE
INDUSTRY

By Tara Bannow • 1 week ago

Pharmalot
Pharmalot 5 hr ago


STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT DRUG PRICE HIKES, BAYER STRATEGIC
MOVES, AND MORE

By Ed Silverman • 5 hr ago

Pharmalot
Pharmalot 1 day ago


STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT A CRISPR APPROVAL, SELLING MEDS
DIRECTLY TO PATIENTS, AND MORE

By Ed Silverman • 1 day ago

In the Lab
In the Lab 1 day ago


STAT PLUS: HAIR LOSS IS ONE OF THE MOST HATED CHEMOTHERAPY SIDE EFFECTS. A NEW
BIOTECH HOPES TO PREVENT IT

By Angus Chen • 1 day ago

Health Tech
Health Tech 1 day ago


STAT PLUS: AT HEALTH CARE’S BIGGEST INVESTOR CONFERENCE, AI’S HIGH HOPES
COLLIDED WITH SKEPTICISM

By Casey Ross, Matthew Herper, and Mohana Ravindranath • 1 day ago

Exclusive
Exclusive 2 days ago


STAT PLUS: DEWPOINT THERAPEUTICS CUTS 15% OF STAFF, ACKNOWLEDGES MERCK, PFIZER
BROKE OFF PARTNERSHIPS OVER BUZZY SCIENCE

By Jason Mast • 2 days ago

Biotech
Biotech 2 days ago


STAT PLUS: FDA EXPANDS APPROVAL OF CRISPR-BASED MEDICINE TO TREAT BETA
THALASSEMIA

By Adam Feuerstein • 2 days ago

First Opinion
First Opinion 2 days ago


BMI AS A BARRIER TO ORTHOPEDIC SURGERY DOESN’T MAKE SENSE FOR PATIENT HEALTH

By Jody Dushay • 2 days ago

Letters to the editor
Letters to the editor 5 days ago


WHAT STAT READERS THINK ABOUT JPM’S LOCKED LACTATION ROOM, COVERING WEIGHT LOSS
DRUGS, AND MORE

By Torie Bosch • 5 days ago

First Opinion
First Opinion 6 days ago


THE NURSING STAFFING CRISIS HAS HIT ONE ROLE PARTICULARLY HARD: THE NURSE
MANAGER

By Toby Bressler and Lauren Ghazal • 6 days ago

First Opinion
First Opinion 1 week ago


PUMPING MILK AT JPM WAS A NIGHTMARE. IT’S PART OF A BIGGER PROBLEM IN THE
INDUSTRY

By Tara Bannow • 1 week ago

First Opinion
First Opinion 1 week ago


ADDRESSING THE BLACK YOUTH SUICIDE CRISIS REQUIRES A NEW APPROACH TO LICENSING
CLINICAL SOCIAL WORKERS

By Janelle Goodwill • 1 week ago

First Opinion
First Opinion 1 week ago


HOW TO ENSURE THE NIH’S DECISION TO RECOGNIZE PEOPLE WITH DISABILITIES AS A
HEALTH DISPARITY POPULATION MAKES A DIFFERENCE

By Lynne Moronski • 1 week ago


NEWSLETTERS

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Please enter a valid email address.
I'd like to be emailed about new content, events, and products.


Our Picks

Our Picks


OUR PICKS

STAT’s selection of must-read stories and investigations


AS SHE DRIVES RESEARCH ON STRUCTURAL RACISM IN HEALTH CARE, RACHEL HARDEMAN
FACES A PAINFUL RECKONING

By Usha Lee McFarling


PUMPING MILK AT JPM WAS A NIGHTMARE. IT’S PART OF A BIGGER PROBLEM IN THE
INDUSTRY

By Tara Bannow


HHS’S XAVIER BECERRA, ONCE AN ‘INVISIBLE’ SECRETARY, IS RACING TO CEMENT A
CLEARER LEGACY

By Sarah Owermohle


STAT PLUS: ADVOCATES EXPECT SUPREME COURT IDAHO ABORTION DECISION TO FUEL
EFFORTS TO FURTHER RESTRICT ACCESS

By Olivia Goldhill and Annalisa Merelli


STAT PLUS: DOUDNA INSTITUTE HATCHES PLAN TO ‘CURE HUNDREDS OF DISEASES’ LEFT
BEHIND BY CRISPR REVOLUTION

By Jason Mast


STAT PLUS: A BIOTECH REPORTER’S NOTEBOOK: SUNSHINE RAINS DOWN ON SAN FRANCISCO

By Allison DeAngelis


NEW YORK’S NEW DOULA PLAN WILL COVER SERVICES FOR ANYONE ON MEDICAID

By Anika Nayak


STAT PLUS: TEXAS TAXPAYERS WANTED TO HELP THE POOR GET HEALTH CARE. INSTEAD,
THEY’RE FUNDING A MEDICAL SCHOOL AT A WEALTHY UNIVERSITY

By Rachel Cohrs


BIOTECH

Biotech


STAT PLUS: FOR-PROFIT BIOMEDICAL INSTITUTE, BACKED BY BILLIONAIRES, LAUNCHES IN
CAMBRIDGE TO SPEED DRUG DISCOVERY

By Robert Weisman and Jonathan Saltzman — The Boston Globe

5 days ago

By Robert Weisman and Jonathan Saltzman — The Boston Globe

Biotech
Biotech 5 days ago


STAT PLUS: FOR-PROFIT BIOMEDICAL INSTITUTE, BACKED BY BILLIONAIRES, LAUNCHES IN
CAMBRIDGE TO SPEED DRUG DISCOVERY

Biotech
Biotech 1 week ago


STAT PLUS: AT JPM, VERVE DETAILS PLOT TO TAKE GENOME EDITING MAINSTREAM

Biotech
Biotech 1 week ago


STAT PLUS: NVIDIA SAYS A BIOLOGICAL REVOLUTION IS HAPPENING NOW. BUT IS IT?


PHARMA

Pharmalot


STAT PLUS: SURVEY: CONFUSION OVER KEY REQUIREMENTS MEANS CLINICAL TRIALS AREN’T
REGISTERED AND RESULTS AREN’T REPORTED

By Ed Silverman

2 days ago

By Ed Silverman

Pharmalot
Pharmalot 2 days ago


STAT PLUS: SURVEY: CONFUSION OVER KEY REQUIREMENTS MEANS CLINICAL TRIALS AREN’T
REGISTERED AND RESULTS AREN’T REPORTED

Pharmalot
Pharmalot 2 days ago


STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT WEGOVY SHIPMENTS, THE NIH
DIRECTOR’S PLANS, AND MORE

Pharmalot
Pharmalot 6 days ago


STAT PLUS: NEW CONGRESSIONAL BILL WOULD THWART PATENT THICKETS IN ORDER TO SPEED
GENERIC DRUGS TO MARKET


HEALTH

Health


THE WHO AND DRUG REGULATORS WANT TO REFORMULATE THE FLU VACCINE. IT’S EASIER
SAID THAN DONE

By Helen Branswell

2 days ago

By Helen Branswell

Health
Health 2 days ago


THE WHO AND DRUG REGULATORS WANT TO REFORMULATE THE FLU VACCINE. IT’S EASIER
SAID THAN DONE

Health
Health 7 days ago


IN PARTIAL REVERSAL, TEXAS MEDICAID GREENLIGHTS FIRST STEP IN GENE THERAPY FOR
AFGHAN REFUGEES’ INFANT SON

Health
Health 1 week ago


GLP-1 DRUGS NOT LINKED TO SUICIDAL THOUGHTS IN FDA’S EARLY REVIEW


POLITICS

Politics


STAT PLUS: THE NEW NIH DIRECTOR IS WALKING A TIGHTROPE ON BIDEN’S DRUG PRICING
VISION

By Sarah Owermohle

2 days ago

By Sarah Owermohle

Politics
Politics 2 days ago


STAT PLUS: THE NEW NIH DIRECTOR IS WALKING A TIGHTROPE ON BIDEN’S DRUG PRICING
VISION

Politics
Politics 1 week ago


STAT PLUS: COURTS WILL DECIDE THE FUTURE OF MEDICARE’S POWER TO NEGOTIATE DRUG
PRICES WITHIN MONTHS

Politics
Politics 1 week ago


AFTER GRILLING FAUCI ON COVID ORIGINS, HOUSE REPUBLICANS WANT TO CONSIDER NEW
RULES FOR FOREIGN RESEARCH


VIDEO

A STAT Documentary


TREATING RURAL AMERICA: THE TELEHEALTH SOLUTION

STAT Wunderkinds


A CONVERSATION WITH THE 2023 STAT WUNDERKINDS

A STAT Documentary


TREATING RURAL AMERICA: THE NEW COUNTRY DOCTORS

A STAT Documentary


TREATING RURAL AMERICA: THE LAST DOCTOR IN TOWN

All Videos

special report

special report

One day, we woke up and found out that the health care money was being diverted
from the folks who it was intended to go to.Read the story

— Nelson Linder, president of the Austin, Texas, NAACP chapter

special report


HEALTH TECH

Health Tech


A NEW, NON-INVASIVE TEST COULD HELP PREDICT THE QUALITY OF EMBRYO USED FOR IVF

By Deborah Balthazar

1 day ago

By Deborah Balthazar

Health Tech
Health Tech 1 day ago


A NEW, NON-INVASIVE TEST COULD HELP PREDICT THE QUALITY OF EMBRYO USED FOR IVF

Health Tech
Health Tech 2 days ago


STAT PLUS: MANY DOCTORS ARE IN THE DARK ABOUT HOW FDA APPROVES DEVICES AND
DRUGS, SURVEY FINDS

Health Tech
Health Tech 1 week ago


STAT PLUS: RUNE LABS, WHICH MAKES AN APP TO TRACK PARKINSON’S SYMPTOMS, RAISES
$12 MILLION


IN THE LAB

In the Lab


ALLEN INSTITUTE CEO RUI COSTA ON MAPPING THE BRAIN AND PAYING EARLY-CAREER
SCIENTISTS DECENT SALARIES

By Jonathan Wosen

2 weeks ago

By Jonathan Wosen

In the Lab
In the Lab 2 weeks ago


ALLEN INSTITUTE CEO RUI COSTA ON MAPPING THE BRAIN AND PAYING EARLY-CAREER
SCIENTISTS DECENT SALARIES

In the Lab
In the Lab 1 month ago


NIH PANEL CALLS FOR FEWER, BETTER-PAID POSTDOCS IN BID TO HALT LOSS OF
SCIENTISTS TO INDUSTRY

In the Lab
In the Lab 1 month ago


STAT PLUS: CAR-T, RECENTLY USED IN A LUPUS PATIENT, HELPS OTHER AUTOIMMUNE
PATIENTS, TOO, IN SMALL STUDY


HOSPITALS

Hospitals


STAT PLUS: NONPROFIT HEALTH SYSTEMS PLUG THEIR STRONG CASH RESERVES AT JPM — A
VERY DIFFERENT PITCH THAN THEY MAKE ELSEWHERE

By Tara Bannow

6 days ago

By Tara Bannow

Hospitals
Hospitals 6 days ago


STAT PLUS: NONPROFIT HEALTH SYSTEMS PLUG THEIR STRONG CASH RESERVES AT JPM — A
VERY DIFFERENT PITCH THAN THEY MAKE ELSEWHERE

Hospitals
Hospitals 1 week ago


STAT PLUS: HEATED LAWSUIT BETWEEN ADVENTHEALTH, MULTIPLAN ATTRACTS HOSPITAL
LOBBYISTS

Hospitals
Hospitals 1 week ago


STAT PLUS: HOSPITALS TRY A NEW PITCH TO INVESTORS: OTHER WAYS OF MAKING MONEY


INSURANCE

Insurance


STAT PLUS: FIERY MEDPAC MEETING HIGHLIGHTS MASSIVE OVERPAYMENTS IN MEDICARE
ADVANTAGE

By Bob Herman

6 days ago

By Bob Herman

Insurance
Insurance 6 days ago


STAT PLUS: FIERY MEDPAC MEETING HIGHLIGHTS MASSIVE OVERPAYMENTS IN MEDICARE
ADVANTAGE

Insurance
Insurance 1 month ago


STAT PLUS: BIDEN ADMINISTRATION ASKS JUDGE TO TOSS OUT HUMANA’S MEDICARE
ADVANTAGE AUDIT LAWSUIT

Insurance
Insurance 1 month ago


STAT PLUS: HOT ANTITRUST ENVIRONMENT HANGS OVER CALLED-OFF MERGER BETWEEN CIGNA
AND HUMANA


PODCASTS

The Readout LOUD


LIVE! FROM JPM 2024

The Readout LOUD


2023 IN REVIEW, CEO REPORT CARDS, AND A LOOK AT THE YEAR AHEAD

The Readout LOUD


FTC V. BIOTECH, PFIZER’S KITCHEN SINK, & VERTEX’S FUTURE

First Opinion Podcast


WHEN DO TESTS HURT MORE THAN HELP?

All Podcasts

Understand how science, health policy, and medicine shape the world every day

Industry Academia Advertising/Communications Agency Advocacy/Non-Profit Banking
Biotech Clinical Research Organization Consulting Firm Consumer Health Financial
Services (Other) Government Healthcare Payer/Insurance Health Tech Hospital
Systems/Provider Law Media Medical Devices Medical Technology Pharmaceuticals
Pharmacy/Retail Real Estate Trade Association Technology Venture Capital
Privacy Policy


Sign up for our morning rounds newsletter




Reporting from the frontiers of health and medicine

Back to top

Company

 * About
 * Our Team
 * Contact Us
 * Careers
 * Diversity & Inclusion
 * Our Awards
 * Advertise With Us
 * STAT Brand Studio
 * Supporters
 * Licensing Stories

Account

 * STAT+
 * Group Subscriptions
 * FAQ
 * My Account
 * Log In
 * Subscribe

More

 * Events
 * Newsletters
 * Reports
 * App
 * Podcasts
 * Community
 * STAT Trials Pulse

 * Privacy
 * Comment Policy
 * Terms
 * Do Not Sell my Data
 * ©2024 STAT

 * 
 * 
 * 
 * 
 * 
 * 
 * 

 

Become a STAT+ subscriber today!

Become a STAT+ subscriber today!

Unlimited access to essential biotech, medicine, and life sciences journalism

Get started

Become a STAT+ subscriber today!

Become a STAT+ subscriber today!

Your go-to source for the latest news and insights on biopharma and the life
sciences

Get started

Become a STAT+ subscriber today!

Become a STAT+ subscriber today!

Unlimited access to essential biotech, medicine, and life sciences journalism

Get started

Become a STAT+ subscriber today!

Become a STAT+ subscriber today!

Your go-to source for the latest news and insights on biopharma and the life
sciences

Get started






STAT NEWS ASKS FOR YOUR CONSENT TO USE YOUR PERSONAL DATA TO:

 * show_chart
   Personalised advertising, advertising and content measurement, audience
   research and services development
 * perm_identity
   Personalised content
 * devices
   Store and/or access information on a device

expand_moreremove
Learn more
 * 
   How can I change my choice?
 * 
   What if I don't consent?
 * 
   How does legitimate interest work?
 * 
   Do I have to consent to everything?

Your personal data will be processed and information from your device (cookies,
unique identifiers, and other device data) may be stored by, accessed by and
shared with 9 TCF vendor(s) and 1 ad partner(s), or used specifically by this
site or app.

Some vendors may process your personal data on the basis of legitimate interest,
which you can object to by managing your options below. Look for a link at the
bottom of this page or in our privacy policy where you can withdraw consent.

Consent



Manage options

arrow_back

Data preferences


MANAGE YOUR DATA

You can choose how your personal data is used. Vendors want your permission to
do the following:

TCF vendors

help_outline


STORE AND/OR ACCESS INFORMATION ON A DEVICE

Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.

View details
Consent (8 vendors)


USE LIMITED DATA TO SELECT ADVERTISING

Advertising presented to you on this service can be based on limited data, such
as the website or app you are using, your non-precise location, your device type
or which content you are (or have been) interacting with (for example, to limit
the number of times an ad is presented to you).

View details
Consent (1 vendor)Legitimate interest (1 vendor)help_outline


CREATE PROFILES FOR PERSONALISED ADVERTISING

Information about your activity on this service (such as forms you submit,
content you look at) can be stored and combined with other information about you
(for example, information from your previous activity on this service and other
websites or apps) or similar users. This is then used to build or improve a
profile about you (that might include possible interests and personal aspects).
Your profile can be used (also later) to present advertising that appears more
relevant based on your possible interests by this and other entities.

View details
Consent (7 vendors)


USE PROFILES TO SELECT PERSONALISED ADVERTISING

Advertising presented to you on this service can be based on your advertising
profiles, which can reflect your activity on this service or other websites or
apps (like the forms you submit, content you look at), possible interests and
personal aspects.

View details
Consent (2 vendors)


CREATE PROFILES TO PERSONALISE CONTENT

Information about your activity on this service (for instance, forms you submit,
non-advertising content you look at) can be stored and combined with other
information about you (such as your previous activity on this service or other
websites or apps) or similar users. This is then used to build or improve a
profile about you (which might for example include possible interests and
personal aspects). Your profile can be used (also later) to present content that
appears more relevant based on your possible interests, such as by adapting the
order in which content is shown to you, so that it is even easier for you to
find content that matches your interests.

View details
Consent (5 vendors)


USE PROFILES TO SELECT PERSONALISED CONTENT

Content presented to you on this service can be based on your content
personalisation profiles, which can reflect your activity on this or other
services (for instance, the forms you submit, content you look at), possible
interests and personal aspects, such as by adapting the order in which content
is shown to you, so that it is even easier for you to find (non-advertising)
content that matches your interests.

View details
Consent (1 vendor)


MEASURE ADVERTISING PERFORMANCE

Information regarding which advertising is presented to you and how you interact
with it can be used to determine how well an advert has worked for you or other
users and whether the goals of the advertising were reached. For instance,
whether you saw an ad, whether you clicked on it, whether it led you to buy a
product or visit a website, etc. This is very helpful to understand the
relevance of advertising campaigns.

View details
Consent (3 vendors)Legitimate interest (3 vendors)help_outline


MEASURE CONTENT PERFORMANCE

Information regarding which content is presented to you and how you interact
with it can be used to determine whether the (non-advertising) content e.g.
reached its intended audience and matched your interests. For instance, whether
you read an article, watch a video, listen to a podcast or look at a product
description, how long you spent on this service and the web pages you visit etc.
This is very helpful to understand the relevance of (non-advertising) content
that is shown to you.

View details
Consent (2 vendors)Legitimate interest (1 vendor)help_outline


UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM DIFFERENT
SOURCES

Reports can be generated based on the combination of data sets (like user
profiles, statistics, market research, analytics data) regarding your
interactions and those of other users with advertising or (non-advertising)
content to identify common characteristics (for instance, to determine which
target audiences are more receptive to an ad campaign or to certain contents).

View details
Consent (5 vendors)Legitimate interest (2 vendors)help_outline


DEVELOP AND IMPROVE SERVICES

Information about your activity on this service, such as your interaction with
ads or content, can be very helpful to improve products and services and to
build new products and services based on user interactions, the type of
audience, etc. This specific purpose does not include the development or
improvement of user profiles and identifiers.

View details
Consent (4 vendors)Legitimate interest (3 vendors)help_outline


ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS

help_outline

Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.

View details


DELIVER AND PRESENT ADVERTISING AND CONTENT

help_outline

Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.

View details


MATCH AND COMBINE DATA FROM OTHER DATA SOURCES

help_outline

Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.

View details


LINK DIFFERENT DEVICES

help_outline

In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).

View details


IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY

help_outline

Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.

View details

Vendor preferences

Accept all



Confirm choices

arrow_back

Vendor preferences


CONFIRM OUR VENDORS

Vendors can use your data to provide services. Declining a vendor can stop them
from using the data you shared.

TCF vendors

help_outline


SHARETHIS, INC

Cookie duration: 390 (days).

Data collected and processed: Browsing and interaction data, Users’ profiles,
Privacy choices, Probabilistic identifiers, IP addresses, Device
characteristics, Device identifiers, Non-precise location data

more




View details | Privacy policylaunch
Consent


LOTAME SOLUTIONS, INC

Cookie duration: 274 (days).

Data collected and processed: Browsing and interaction data, Users’ profiles,
Privacy choices, Probabilistic identifiers, Authentication-derived identifiers,
IP addresses, Device characteristics, Device identifiers, User-provided data

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policylaunch
Consent


LIVERAMP

Cookie duration: 365 (days).

Data collected and processed: Browsing and interaction data, Privacy choices,
Authentication-derived identifiers, IP addresses, Device characteristics, Device
identifiers, Non-precise location data

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policylaunch
Consent


DYNATA LLC

Cookie duration: 365 (days).

Data collected and processed: Browsing and interaction data, Users’ profiles,
Privacy choices, Authentication-derived identifiers, IP addresses, Device
characteristics, Device identifiers, Non-precise location data, User-provided
data

more

Cookie duration resets each session.


View details | Storage details | Privacy policylaunch
Consent


EYEOTA PTE LTD

Cookie duration: 365 (days).

Data collected and processed: Users’ profiles, Privacy choices, Probabilistic
identifiers, IP addresses, Device characteristics, Device identifiers,
Non-precise location data

more

Cookie duration resets each session.


View details | Storage details | Privacy policylaunch
Consent


BOMBORA INC.

Cookie duration: 365 (days).

Data collected and processed: Browsing and interaction data, Users’ profiles,
Authentication-derived identifiers, IP addresses, Device characteristics, Device
identifiers, Non-precise location data

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policylaunch
ConsentLegitimate interesthelp_outline


ORACLE ADVERTISING

Cookie duration: 180 (days).

Data collected and processed: Browsing and interaction data, Users’ profiles,
Privacy choices, Authentication-derived identifiers, Device characteristics,
Device identifiers, Non-precise location data, User-provided data

more

Uses other forms of storage.


View details | Storage details | Privacy policylaunch
Consent


GOOGLE ADVERTISING PRODUCTS

Cookie duration: 396 (days).

Data collected and processed: Browsing and interaction data, Users’ profiles,
Privacy choices, Authentication-derived identifiers, IP addresses, Device
characteristics, Device identifiers, Non-precise location data, User-provided
data

more

Uses other forms of storage.


View details | Storage details | Privacy policylaunch
ConsentLegitimate interesthelp_outline


ORACLE DATA CLOUD - MOAT

Doesn't use cookies.

Data collected and processed: IP addresses, Non-precise location data

more




View details | Privacy policylaunch
Legitimate interesthelp_outline

Ad partners

help_outline


ADSTRA

Privacy policylaunch
Consent

Accept all



Confirm choices

Close

Please review our cookie policy

We use first- and third-party cookies to customize your experience and display
advertising. By continuing to use the site, you agree to our use of cookies. If
you want to know more or opt out in whole or in part, please see our Privacy
Notice and our Cookie FAQ.

Accept No thanks